| 6NZM: reference: Optimization of novel reversible Bruton's tyrosine kinase inhibitors identified using Tethering-fragment-based screens., Hopkins BT, Bame E, Bell N, Bohnert T, Bowden-Verhoek JK, Bui M, Cancilla MT, Conlon P, Cullen P, Erlanson DA, Fan J, Fuchs-Knotts T, Hansen S, Heumann S, Jenkins TJ, Marcotte D, McDowell B, Mertsching E, Negrou E, Otipoby KL, Poreci U, Romanowski MJ, Scott D, Silvian L, Yang W, Zhong M, Bioorg Med Chem. 2019 Jul 1;27(13):2905-2913. doi: 10.1016/j.bmc.2019.05.021., Epub 2019 May 14. PMID: 31138459 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).